IN SITU DETECTION OF EARLY STAGES AND LATE STAGES HPV INFECTION

摘要

Embodiments of the invention provide methods, monoclonal antibodies, polyclonal antibodies, assays, and kits for detecting HPV infection and HPV related cancer diagnosis, including infection by various HPV genotypes, early and/or late stage HPV-associated or HPV-specific cancers. The anti-HPV antibodies are used in performing immunological assays on clinical samples. Various immunological assays and kits for detecting HPV infection, cervical cancer, other HPV related cancers, early stage precancerous lesions as well as late stage cancer progression are also provided.

主权项

1. A method of detecting papillomavirus infection in a human subject, comprising:
providing a clinical sample from the human subject, the clinical sample is processed into a liquid-based solution containing a mixture of morphologically abnormal and normal human cells; staining the mixture of the morphologically abnormal and normal human cells using one or more antibodies generated against one or more purified recombinant papillomavirus proteins, wherein the one or more antibodies are each tagged with an agent, and at least one antibody is capable of binding to a papillomavirus early viral protein; conducting one or more flow cytometry assays to detect each individual cells by separating each cell from the mixture of the morphologically abnormal and normal human cells; and detecting the presence of one or more human papillomavirus viral proteins from one or more papillomavirus types in the mixture of the morphologically abnormal and normal human cells contained in the liquid-based solution from the clinical sample.